Research
Micronutrients & recovery
A 12-week supplementation of 500 mg/day resveratrol does not significantly improve anthropometric measurements, insulin resistance markers, lipid profiles, or blood pressure in patients with NAFLD compared to placebo.
Do not expect 500 mg of resveratrol to fix your cholesterol, blood pressure, or insulin resistance. It may help your liver enzymes, but you still need to manage your weight, diet, and exercise to improve these broader metabolic health markers.
GoodRefutesHIGH confidence
Our data have shown that 12-week supplementation of 500 mg resveratrol does not have any beneficial effect on anthropometric measurements, insulin resistance markers, lipid profile and blood pressure; however, it reduced ALT and hepatic steatosis in patients with NAFLD.
Why this rating
Robust study design (RCT, double-blind, placebo-controlled) with high adherence.
Source
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
Forouzan Faghihzadeh et al. · British Journal Of Nutrition · 2015
rct · n=50Cited 185×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →